Xingfeng He

551 total citations
5 papers, 191 citations indexed

About

Xingfeng He is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Xingfeng He has authored 5 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Xingfeng He's work include Cancer Cells and Metastasis (3 papers), RNA modifications and cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). Xingfeng He is often cited by papers focused on Cancer Cells and Metastasis (3 papers), RNA modifications and cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). Xingfeng He collaborates with scholars based in China, India and Finland. Xingfeng He's co-authors include Fanlu Li, Zhiwei Xu, Minmin Shi, Chenlei Wen, Yihao Liu, Qian Zhan, Siyi Zou, Pengyi Liu, Yizhi Cao and Baiyong Shen and has published in prestigious journals such as Journal of Hematology & Oncology, Journal of Experimental & Clinical Cancer Research and Stem Cell Research & Therapy.

In The Last Decade

Xingfeng He

5 papers receiving 190 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingfeng He China 5 128 108 52 28 19 5 191
Hongbin Mei China 5 113 0.9× 102 0.9× 68 1.3× 29 1.0× 26 1.4× 6 206
Élodie Roger Germany 4 108 0.8× 94 0.9× 143 2.8× 20 0.7× 8 0.4× 9 198
Annika Spruessel Germany 2 119 0.9× 47 0.4× 27 0.5× 17 0.6× 12 0.6× 2 167
Chantal Hoi Yin Cheung Taiwan 8 204 1.6× 104 1.0× 17 0.3× 22 0.8× 14 0.7× 9 249
Christine Loreth United States 6 70 0.5× 31 0.3× 60 1.2× 22 0.8× 23 1.2× 7 138
Marie Sabatier United States 5 107 0.8× 71 0.7× 19 0.4× 15 0.5× 22 1.2× 7 177
Kazumasa Sekihara Japan 9 129 1.0× 35 0.3× 32 0.6× 10 0.4× 26 1.4× 13 209
Rongli Wei China 4 78 0.6× 65 0.6× 47 0.9× 9 0.3× 16 0.8× 7 140
Robert E. Denroche Canada 8 80 0.6× 86 0.8× 86 1.7× 16 0.6× 5 0.3× 16 171
Aitor Rodríguez‐Casanova Spain 8 123 1.0× 123 1.1× 69 1.3× 16 0.6× 8 0.4× 10 202

Countries citing papers authored by Xingfeng He

Since Specialization
Citations

This map shows the geographic impact of Xingfeng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingfeng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingfeng He more than expected).

Fields of papers citing papers by Xingfeng He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingfeng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingfeng He. The network helps show where Xingfeng He may publish in the future.

Co-authorship network of co-authors of Xingfeng He

This figure shows the co-authorship network connecting the top 25 collaborators of Xingfeng He. A scholar is included among the top collaborators of Xingfeng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingfeng He. Xingfeng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Li, Yaqi, Jing Xu, Xiang Hu, et al.. (2024). Personalized circulating tumor DNA monitoring improves recurrence surveillance and management after curative resection of colorectal liver metastases: a prospective cohort study. International Journal of Surgery. 110(5). 2776–2787. 9 indexed citations
2.
He, Xingfeng, Yan Jiang, Long Zhang, et al.. (2023). Patient-derived organoids as a platform for drug screening in metastatic colorectal cancer. Frontiers in Bioengineering and Biotechnology. 11. 1190637–1190637. 29 indexed citations
3.
Lin, Jiayu, Pengyi Liu, Jia Liu, et al.. (2023). SNHG17 alters anaerobic glycolysis by resetting phosphorylation modification of PGK1 to foster pro-tumor macrophage formation in pancreatic ductal adenocarcinoma. Journal of Experimental & Clinical Cancer Research. 42(1). 8 indexed citations
4.
Li, Xiaomeng, Guoxiang Fu, Long Zhang, et al.. (2022). Assay establishment and validation of a high-throughput organoid-based drug screening platform. Stem Cell Research & Therapy. 13(1). 219–219. 31 indexed citations
5.
Liu, Yihao, Minmin Shi, Xingfeng He, et al.. (2022). LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma. Journal of Hematology & Oncology. 15(1). 52–52. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026